GUT 润色咨询

GUT

出版年份:1960 年文章数:2644 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1242872, encodeId=f76c12428e2f1, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:心血管代谢病;肠道内生态<br>经验分享:投稿随缘,切中创新点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210802/5ef105d905ec4e8996f78de0962cced2/1748111b85404b12951bc1cac394ed00.jpeg, createdBy=b0695562223, createdName=ms4000001294909970, createdTime=Fri Sep 02 21:29:39 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215888, encodeId=6aa512158888b, content=怎么在投稿类型中没找到 review 呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d785587807, createdName=落雪802, createdTime=Sat Apr 30 21:38:51 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005300, encodeId=9c72100530078, content=损伤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Aug 05 09:58:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899353, encodeId=3d65899353d6, content=垃圾杂志,专收关系户和通讯大牛的文章。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Sun Nov 15 19:10:44 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893210, encodeId=40b789321066, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:研究方向: 酒精性肝炎。 本人于04-23-2020投稿一篇original research, 05-09-2020 状态major revision, 于09-29-2020 resubmission, 并在10-19-2020 accepted. 通过查阅最近的文章信息, 投稿到接收一般小于半年。杂志给的数据接受率在12%左右。总体感觉审稿很快,一审对格式要求低,二审格式要求高,包括 字数在4000以内等。杂志对临床意义要求较高,并且需要比较好的创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLD26tlia3sPiazicG0tmUF1mO3QTe7Wz9pRIkk9KJc9tS7Fg3fxt3LI5NyAVcrCkibXU48ODlndmgWPSQ/132, createdBy=affd2187359, createdName=六一是宝宝, createdTime=Tue Oct 20 03:18:25 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582670, encodeId=bcc25826e0e5, content=请问首次投稿时字数一定不能超过4000吗? <span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=620591981, createdName=runne, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582251, encodeId=5204582251ce, content=你怎么审稿速度那么快<span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578565, encodeId=c80f5e85655e, content=求分享,求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2022-09-02 ms4000001294909970

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:心血管代谢病;肠道内生态
    经验分享:投稿随缘,切中创新点

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1242872, encodeId=f76c12428e2f1, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:心血管代谢病;肠道内生态<br>经验分享:投稿随缘,切中创新点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210802/5ef105d905ec4e8996f78de0962cced2/1748111b85404b12951bc1cac394ed00.jpeg, createdBy=b0695562223, createdName=ms4000001294909970, createdTime=Fri Sep 02 21:29:39 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215888, encodeId=6aa512158888b, content=怎么在投稿类型中没找到 review 呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d785587807, createdName=落雪802, createdTime=Sat Apr 30 21:38:51 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005300, encodeId=9c72100530078, content=损伤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Aug 05 09:58:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899353, encodeId=3d65899353d6, content=垃圾杂志,专收关系户和通讯大牛的文章。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Sun Nov 15 19:10:44 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893210, encodeId=40b789321066, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:研究方向: 酒精性肝炎。 本人于04-23-2020投稿一篇original research, 05-09-2020 状态major revision, 于09-29-2020 resubmission, 并在10-19-2020 accepted. 通过查阅最近的文章信息, 投稿到接收一般小于半年。杂志给的数据接受率在12%左右。总体感觉审稿很快,一审对格式要求低,二审格式要求高,包括 字数在4000以内等。杂志对临床意义要求较高,并且需要比较好的创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLD26tlia3sPiazicG0tmUF1mO3QTe7Wz9pRIkk9KJc9tS7Fg3fxt3LI5NyAVcrCkibXU48ODlndmgWPSQ/132, createdBy=affd2187359, createdName=六一是宝宝, createdTime=Tue Oct 20 03:18:25 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582670, encodeId=bcc25826e0e5, content=请问首次投稿时字数一定不能超过4000吗? <span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=620591981, createdName=runne, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582251, encodeId=5204582251ce, content=你怎么审稿速度那么快<span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578565, encodeId=c80f5e85655e, content=求分享,求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2022-04-30 落雪802

    怎么在投稿类型中没找到 review 呢

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1242872, encodeId=f76c12428e2f1, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:心血管代谢病;肠道内生态<br>经验分享:投稿随缘,切中创新点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210802/5ef105d905ec4e8996f78de0962cced2/1748111b85404b12951bc1cac394ed00.jpeg, createdBy=b0695562223, createdName=ms4000001294909970, createdTime=Fri Sep 02 21:29:39 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215888, encodeId=6aa512158888b, content=怎么在投稿类型中没找到 review 呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d785587807, createdName=落雪802, createdTime=Sat Apr 30 21:38:51 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005300, encodeId=9c72100530078, content=损伤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Aug 05 09:58:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899353, encodeId=3d65899353d6, content=垃圾杂志,专收关系户和通讯大牛的文章。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Sun Nov 15 19:10:44 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893210, encodeId=40b789321066, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:研究方向: 酒精性肝炎。 本人于04-23-2020投稿一篇original research, 05-09-2020 状态major revision, 于09-29-2020 resubmission, 并在10-19-2020 accepted. 通过查阅最近的文章信息, 投稿到接收一般小于半年。杂志给的数据接受率在12%左右。总体感觉审稿很快,一审对格式要求低,二审格式要求高,包括 字数在4000以内等。杂志对临床意义要求较高,并且需要比较好的创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLD26tlia3sPiazicG0tmUF1mO3QTe7Wz9pRIkk9KJc9tS7Fg3fxt3LI5NyAVcrCkibXU48ODlndmgWPSQ/132, createdBy=affd2187359, createdName=六一是宝宝, createdTime=Tue Oct 20 03:18:25 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582670, encodeId=bcc25826e0e5, content=请问首次投稿时字数一定不能超过4000吗? <span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=620591981, createdName=runne, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582251, encodeId=5204582251ce, content=你怎么审稿速度那么快<span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578565, encodeId=c80f5e85655e, content=求分享,求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2021-02-22 dr大王

    中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1242872, encodeId=f76c12428e2f1, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:心血管代谢病;肠道内生态<br>经验分享:投稿随缘,切中创新点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210802/5ef105d905ec4e8996f78de0962cced2/1748111b85404b12951bc1cac394ed00.jpeg, createdBy=b0695562223, createdName=ms4000001294909970, createdTime=Fri Sep 02 21:29:39 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215888, encodeId=6aa512158888b, content=怎么在投稿类型中没找到 review 呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d785587807, createdName=落雪802, createdTime=Sat Apr 30 21:38:51 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005300, encodeId=9c72100530078, content=损伤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Aug 05 09:58:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899353, encodeId=3d65899353d6, content=垃圾杂志,专收关系户和通讯大牛的文章。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Sun Nov 15 19:10:44 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893210, encodeId=40b789321066, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:研究方向: 酒精性肝炎。 本人于04-23-2020投稿一篇original research, 05-09-2020 状态major revision, 于09-29-2020 resubmission, 并在10-19-2020 accepted. 通过查阅最近的文章信息, 投稿到接收一般小于半年。杂志给的数据接受率在12%左右。总体感觉审稿很快,一审对格式要求低,二审格式要求高,包括 字数在4000以内等。杂志对临床意义要求较高,并且需要比较好的创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLD26tlia3sPiazicG0tmUF1mO3QTe7Wz9pRIkk9KJc9tS7Fg3fxt3LI5NyAVcrCkibXU48ODlndmgWPSQ/132, createdBy=affd2187359, createdName=六一是宝宝, createdTime=Tue Oct 20 03:18:25 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582670, encodeId=bcc25826e0e5, content=请问首次投稿时字数一定不能超过4000吗? <span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=620591981, createdName=runne, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582251, encodeId=5204582251ce, content=你怎么审稿速度那么快<span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578565, encodeId=c80f5e85655e, content=求分享,求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2021-08-05 yjq08018275

    损伤

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1242872, encodeId=f76c12428e2f1, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:心血管代谢病;肠道内生态<br>经验分享:投稿随缘,切中创新点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210802/5ef105d905ec4e8996f78de0962cced2/1748111b85404b12951bc1cac394ed00.jpeg, createdBy=b0695562223, createdName=ms4000001294909970, createdTime=Fri Sep 02 21:29:39 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215888, encodeId=6aa512158888b, content=怎么在投稿类型中没找到 review 呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d785587807, createdName=落雪802, createdTime=Sat Apr 30 21:38:51 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005300, encodeId=9c72100530078, content=损伤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Aug 05 09:58:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899353, encodeId=3d65899353d6, content=垃圾杂志,专收关系户和通讯大牛的文章。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Sun Nov 15 19:10:44 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893210, encodeId=40b789321066, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:研究方向: 酒精性肝炎。 本人于04-23-2020投稿一篇original research, 05-09-2020 状态major revision, 于09-29-2020 resubmission, 并在10-19-2020 accepted. 通过查阅最近的文章信息, 投稿到接收一般小于半年。杂志给的数据接受率在12%左右。总体感觉审稿很快,一审对格式要求低,二审格式要求高,包括 字数在4000以内等。杂志对临床意义要求较高,并且需要比较好的创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLD26tlia3sPiazicG0tmUF1mO3QTe7Wz9pRIkk9KJc9tS7Fg3fxt3LI5NyAVcrCkibXU48ODlndmgWPSQ/132, createdBy=affd2187359, createdName=六一是宝宝, createdTime=Tue Oct 20 03:18:25 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582670, encodeId=bcc25826e0e5, content=请问首次投稿时字数一定不能超过4000吗? <span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=620591981, createdName=runne, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582251, encodeId=5204582251ce, content=你怎么审稿速度那么快<span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578565, encodeId=c80f5e85655e, content=求分享,求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2021-07-18 1484bf18m20暂无昵称

    偏重的研究方向: 消化 ; 胃肠病学
    经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1242872, encodeId=f76c12428e2f1, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:心血管代谢病;肠道内生态<br>经验分享:投稿随缘,切中创新点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210802/5ef105d905ec4e8996f78de0962cced2/1748111b85404b12951bc1cac394ed00.jpeg, createdBy=b0695562223, createdName=ms4000001294909970, createdTime=Fri Sep 02 21:29:39 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215888, encodeId=6aa512158888b, content=怎么在投稿类型中没找到 review 呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d785587807, createdName=落雪802, createdTime=Sat Apr 30 21:38:51 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005300, encodeId=9c72100530078, content=损伤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Aug 05 09:58:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899353, encodeId=3d65899353d6, content=垃圾杂志,专收关系户和通讯大牛的文章。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Sun Nov 15 19:10:44 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893210, encodeId=40b789321066, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:研究方向: 酒精性肝炎。 本人于04-23-2020投稿一篇original research, 05-09-2020 状态major revision, 于09-29-2020 resubmission, 并在10-19-2020 accepted. 通过查阅最近的文章信息, 投稿到接收一般小于半年。杂志给的数据接受率在12%左右。总体感觉审稿很快,一审对格式要求低,二审格式要求高,包括 字数在4000以内等。杂志对临床意义要求较高,并且需要比较好的创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLD26tlia3sPiazicG0tmUF1mO3QTe7Wz9pRIkk9KJc9tS7Fg3fxt3LI5NyAVcrCkibXU48ODlndmgWPSQ/132, createdBy=affd2187359, createdName=六一是宝宝, createdTime=Tue Oct 20 03:18:25 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582670, encodeId=bcc25826e0e5, content=请问首次投稿时字数一定不能超过4000吗? <span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=620591981, createdName=runne, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582251, encodeId=5204582251ce, content=你怎么审稿速度那么快<span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578565, encodeId=c80f5e85655e, content=求分享,求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2020-11-15 qinss77

    垃圾杂志,专收关系户和通讯大牛的文章。。。

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1242872, encodeId=f76c12428e2f1, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:心血管代谢病;肠道内生态<br>经验分享:投稿随缘,切中创新点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210802/5ef105d905ec4e8996f78de0962cced2/1748111b85404b12951bc1cac394ed00.jpeg, createdBy=b0695562223, createdName=ms4000001294909970, createdTime=Fri Sep 02 21:29:39 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215888, encodeId=6aa512158888b, content=怎么在投稿类型中没找到 review 呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d785587807, createdName=落雪802, createdTime=Sat Apr 30 21:38:51 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005300, encodeId=9c72100530078, content=损伤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Aug 05 09:58:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899353, encodeId=3d65899353d6, content=垃圾杂志,专收关系户和通讯大牛的文章。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Sun Nov 15 19:10:44 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893210, encodeId=40b789321066, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:研究方向: 酒精性肝炎。 本人于04-23-2020投稿一篇original research, 05-09-2020 状态major revision, 于09-29-2020 resubmission, 并在10-19-2020 accepted. 通过查阅最近的文章信息, 投稿到接收一般小于半年。杂志给的数据接受率在12%左右。总体感觉审稿很快,一审对格式要求低,二审格式要求高,包括 字数在4000以内等。杂志对临床意义要求较高,并且需要比较好的创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLD26tlia3sPiazicG0tmUF1mO3QTe7Wz9pRIkk9KJc9tS7Fg3fxt3LI5NyAVcrCkibXU48ODlndmgWPSQ/132, createdBy=affd2187359, createdName=六一是宝宝, createdTime=Tue Oct 20 03:18:25 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582670, encodeId=bcc25826e0e5, content=请问首次投稿时字数一定不能超过4000吗? <span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=620591981, createdName=runne, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582251, encodeId=5204582251ce, content=你怎么审稿速度那么快<span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578565, encodeId=c80f5e85655e, content=求分享,求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2020-10-20 六一是宝宝

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:研究方向: 酒精性肝炎。 本人于04-23-2020投稿一篇original research, 05-09-2020 状态major revision, 于09-29-2020 resubmission, 并在10-19-2020 accepted. 通过查阅最近的文章信息, 投稿到接收一般小于半年。杂志给的数据接受率在12%左右。总体感觉审稿很快,一审对格式要求低,二审格式要求高,包括 字数在4000以内等。杂志对临床意义要求较高,并且需要比较好的创新性。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1242872, encodeId=f76c12428e2f1, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:心血管代谢病;肠道内生态<br>经验分享:投稿随缘,切中创新点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210802/5ef105d905ec4e8996f78de0962cced2/1748111b85404b12951bc1cac394ed00.jpeg, createdBy=b0695562223, createdName=ms4000001294909970, createdTime=Fri Sep 02 21:29:39 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215888, encodeId=6aa512158888b, content=怎么在投稿类型中没找到 review 呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d785587807, createdName=落雪802, createdTime=Sat Apr 30 21:38:51 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005300, encodeId=9c72100530078, content=损伤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Aug 05 09:58:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899353, encodeId=3d65899353d6, content=垃圾杂志,专收关系户和通讯大牛的文章。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Sun Nov 15 19:10:44 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893210, encodeId=40b789321066, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:研究方向: 酒精性肝炎。 本人于04-23-2020投稿一篇original research, 05-09-2020 状态major revision, 于09-29-2020 resubmission, 并在10-19-2020 accepted. 通过查阅最近的文章信息, 投稿到接收一般小于半年。杂志给的数据接受率在12%左右。总体感觉审稿很快,一审对格式要求低,二审格式要求高,包括 字数在4000以内等。杂志对临床意义要求较高,并且需要比较好的创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLD26tlia3sPiazicG0tmUF1mO3QTe7Wz9pRIkk9KJc9tS7Fg3fxt3LI5NyAVcrCkibXU48ODlndmgWPSQ/132, createdBy=affd2187359, createdName=六一是宝宝, createdTime=Tue Oct 20 03:18:25 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582670, encodeId=bcc25826e0e5, content=请问首次投稿时字数一定不能超过4000吗? <span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=620591981, createdName=runne, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582251, encodeId=5204582251ce, content=你怎么审稿速度那么快<span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578565, encodeId=c80f5e85655e, content=求分享,求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2020-01-04 runne

    请问首次投稿时字数一定不能超过4000吗? jsity0023 2019-06-23 发表::
    研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。
    jsity0023 2019-06-23 22:20:00 发表:
    2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。

    jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1242872, encodeId=f76c12428e2f1, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:心血管代谢病;肠道内生态<br>经验分享:投稿随缘,切中创新点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210802/5ef105d905ec4e8996f78de0962cced2/1748111b85404b12951bc1cac394ed00.jpeg, createdBy=b0695562223, createdName=ms4000001294909970, createdTime=Fri Sep 02 21:29:39 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215888, encodeId=6aa512158888b, content=怎么在投稿类型中没找到 review 呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d785587807, createdName=落雪802, createdTime=Sat Apr 30 21:38:51 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005300, encodeId=9c72100530078, content=损伤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Aug 05 09:58:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899353, encodeId=3d65899353d6, content=垃圾杂志,专收关系户和通讯大牛的文章。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Sun Nov 15 19:10:44 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893210, encodeId=40b789321066, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:研究方向: 酒精性肝炎。 本人于04-23-2020投稿一篇original research, 05-09-2020 状态major revision, 于09-29-2020 resubmission, 并在10-19-2020 accepted. 通过查阅最近的文章信息, 投稿到接收一般小于半年。杂志给的数据接受率在12%左右。总体感觉审稿很快,一审对格式要求低,二审格式要求高,包括 字数在4000以内等。杂志对临床意义要求较高,并且需要比较好的创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLD26tlia3sPiazicG0tmUF1mO3QTe7Wz9pRIkk9KJc9tS7Fg3fxt3LI5NyAVcrCkibXU48ODlndmgWPSQ/132, createdBy=affd2187359, createdName=六一是宝宝, createdTime=Tue Oct 20 03:18:25 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582670, encodeId=bcc25826e0e5, content=请问首次投稿时字数一定不能超过4000吗? <span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=620591981, createdName=runne, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582251, encodeId=5204582251ce, content=你怎么审稿速度那么快<span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578565, encodeId=c80f5e85655e, content=求分享,求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2019-12-27 福禄娃二号机

    你怎么审稿速度那么快jsity0023 2019-06-23 发表::
    研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。
    jsity0023 2019-06-23 22:20:00 发表:
    2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。

    jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1242872, encodeId=f76c12428e2f1, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:心血管代谢病;肠道内生态<br>经验分享:投稿随缘,切中创新点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210802/5ef105d905ec4e8996f78de0962cced2/1748111b85404b12951bc1cac394ed00.jpeg, createdBy=b0695562223, createdName=ms4000001294909970, createdTime=Fri Sep 02 21:29:39 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215888, encodeId=6aa512158888b, content=怎么在投稿类型中没找到 review 呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d785587807, createdName=落雪802, createdTime=Sat Apr 30 21:38:51 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005300, encodeId=9c72100530078, content=损伤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bdb4724485, createdName=yjq08018275, createdTime=Thu Aug 05 09:58:05 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899353, encodeId=3d65899353d6, content=垃圾杂志,专收关系户和通讯大牛的文章。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Sun Nov 15 19:10:44 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893210, encodeId=40b789321066, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:研究方向: 酒精性肝炎。 本人于04-23-2020投稿一篇original research, 05-09-2020 状态major revision, 于09-29-2020 resubmission, 并在10-19-2020 accepted. 通过查阅最近的文章信息, 投稿到接收一般小于半年。杂志给的数据接受率在12%左右。总体感觉审稿很快,一审对格式要求低,二审格式要求高,包括 字数在4000以内等。杂志对临床意义要求较高,并且需要比较好的创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ajNVdqHZLLD26tlia3sPiazicG0tmUF1mO3QTe7Wz9pRIkk9KJc9tS7Fg3fxt3LI5NyAVcrCkibXU48ODlndmgWPSQ/132, createdBy=affd2187359, createdName=六一是宝宝, createdTime=Tue Oct 20 03:18:25 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582670, encodeId=bcc25826e0e5, content=请问首次投稿时字数一定不能超过4000吗? <span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=620591981, createdName=runne, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582251, encodeId=5204582251ce, content=你怎么审稿速度那么快<span class="quote">jsity0023 2019-06-23 发表::<br>研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span><span class="quote">jsity0023 2019-06-23 22:20:00 发表:<br>2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。</span>, beContent=jsity0023 2019-06-23 发表:: 研究方向:肝癌;; 审稿时间:约1个月 2019-4-11投稿,退稿修改格式,4-13投回去,4-16awaiting reviewer assignment;4-18 awaiting reviewer scores 4-29 awaiting recommendation 5-1 major Revision. 6-3 修回,6-4退回改格式。6-14 awaiting reviewer invitation. 6-19 awaiting reviewer score 6-20 awaiting recommendation 6-21 awaiting decision 6-21 accepted. 总体很快,格式要求高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578565, encodeId=c80f5e85655e, content=求分享,求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    求分享,求经验

    0

共113条页码: 2/12页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分